DHTKD1

From Wikipedia, the free encyclopedia

AliasesDHTKD1, AMOXAD, CMT2Q, dehydrogenase E1 and transketolase domain containing 1, AAKAD
End12,123,221 bp[1]
DHTKD1
Identifiers
AliasesDHTKD1, AMOXAD, CMT2Q, dehydrogenase E1 and transketolase domain containing 1, AAKAD
External IDsOMIM: 614984; MGI: 2445096; HomoloGene: 10278; GeneCards: DHTKD1; OMA:DHTKD1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_018706

NM_001081131

RefSeq (protein)

NP_061176

NP_001074600

Location (UCSC)Chr 10: 12.07 – 12.12 MbChr 2: 5.9 – 5.94 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Dehydrogenase E1 and transketolase domain containing 1 is a mitochondrial protein that in humans is encoded by the DHTKD1 gene. This gene encodes a component of the 2-oxoadipate dehydrogenase complex (OADHC) involved in the degradation pathways of several amino acids, including lysine. Mutations in this gene are associated with 2-aminoadipic 2-oxoadipic aciduria and Charcot-Marie-Tooth Disease Type 2Q.[5]

The DHTKD1 gene encodes a protein that has 919 amino acids, and is one of two isoforms within the 2-oxoadipate dehydrogenase complex.[5]

Function

DHTKD1 is part of the OADHC that is responsible for a crucial step in the degradation pathways of L-lysine, L-hydroxylysine, and L-tryptophan. Specifically, this enzyme catalyzes the decarboxylation of 2-oxoadipate to glutaryl-CoA.[6] There is a strong correlation between DHTKD1 expression levels and ATP production, which signifies that DHTKD1 plays a critical role in energy production in mitochondria. Moreover, suppression of DHTKD1 results in decreased levels of biogenesis and increased levels of reactive oxygen species (ROS) within the mitochondria. Globally, this impairs cell growth and enhances cell apoptosis.[7]

Clinical significance

References

Further reading

Related Articles

Wikiwand AI